[Precise combination of systemic therapy and hepatic surgery]

Area of Science:

• Hepatology and Oncology
• Cancer Treatment Research

Background:

• Primary liver cancer presents a significant health challenge in China, with high mortality rates.
• Surgery is a primary treatment for early-stage liver cancer and an option for advanced stages.

Purpose of the Study:

• To review current surgical and drug treatment strategies for liver cancer.
• To explore the potential of combining surgical and drug therapies for improved outcomes.
• To discuss the impact of these treatments on future liver cancer management models.

Main Methods:

• Literature review of surgical interventions for liver cancer.
• Analysis of pharmacological approaches in liver cancer treatment.
• Evaluation of combined therapy protocols and their efficacy.

Main Results:

• Surgery remains a cornerstone for early-stage liver cancer.
• Emerging drug therapies offer new options for intermediate and advanced stages.
• Combination treatments show promise for enhancing therapeutic efficacy.

Conclusions:

• Integrated treatment strategies combining surgery and drugs are crucial for advancing liver cancer care.
• Further research into combined modalities is essential for optimizing future treatment paradigms.